258 / 1241
Slide 41
NSCLC: Summary
Evidence from the literature on PET for RTP:
feasible with small residual risk for out-field recurrences
technical problems to be solved
clinical studies needed to demonstrate patients’ benefit
PET as a surrogate end point for treatment efficacy
demonstrated under chemotherapy
possible after radiotherapy
PET for follow-up of radiation treatment
bears potential for adaptive RT and early assessment of response
PET tracers beyond FDG
Hypoxia imaging and imaging of proliferation possible
Use for RT planning to be determined